SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

GANX

Gain Therapeutics Inc.
NASDAQHealth Care

Latest close: 1.26 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record2150 flagged findings
Reported transactions (Form 4)56since Jun 23, 2023
Corporate events (8-K)22since Mar 22, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 215)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 1, 268-K ↗Current report · Other events
  • Sep 28, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Jul 16, 268-K ↗Current report · Other events
  • Jun 29, 268-K ↗Current report · Other events
  • Jun 25, 268-K ↗Current report · Shareholder vote results
  • May 26, 268-K ↗Current report · Other events
  • May 11, 2610-Q ↗Quarterly report
  • May 11, 268-K ↗Current report · Results
  • Apr 28, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 28, 26DEF 14A ↗Shareholder meeting and votes
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Mar 26, 2610-K ↗Annual report
  • Mar 26, 268-K ↗Current report · Results
  • Mar 18, 268-K ↗Current report · Communication to the market · Other events
  • Feb 3, 268-K ↗Current report · Communication to the market
  • Dec 18, 258-K ↗Current report · Other events

215 filings on record, the oldest from Dec 14, 20.

Listing the 25 most recent filings of the 215 on record.

8-Ks, explained

Stress2Structure8Governance12
  • Sep 28, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 9, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 17, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jan 15, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 7, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 6, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 12, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 28, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 14, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 8, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 22, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 22, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

8 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 9, 24Buy$50KKhalid IslamExecutive Chairman↗
  • Aug 9, 24Buy$15KGene MackCFO and Interim CEO↗
  • Jul 1, 24Buy$6KERIC I RICHMAN↗
  • Jul 1, 24Buy$15KERIC I RICHMAN↗
  • Mar 28, 24Buy$116KJeffrey Scott Riley↗
  • Dec 21, 23Sell$507Matthias AlderChief Executive Officer↗
  • Dec 7, 23Sell$5KMatthias AlderChief Executive Officer↗
Stock compensation, tax and giftsshow the 9 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Mar 26, 24Compensationamount n/aMatthias AlderChief Executive Officer↗
  • Mar 26, 24Compensationamount n/aMatthias AlderChief Executive Officer↗
  • Mar 26, 24Compensationamount n/aMatthias AlderChief Executive Officer↗
  • Mar 26, 24Tax$25KMatthias AlderChief Executive Officer↗
  • Dec 20, 23Compensationamount n/aMatthias AlderChief Executive Officer↗
  • Oct 1, 23Compensationamount n/aMatthias AlderChief Executive Officer↗
  • Sep 20, 23Compensationamount n/aMatthias AlderChief Executive Officer↗
  • Sep 20, 23Compensationamount n/aERIC I RICHMAN↗
  • Jul 1, 23Compensationamount n/aMatthias AlderChief Executive Officer↗

The full record holds 16 transactions and goes back to Mar 23, 23.

Its sector and its market

Gain Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Gain Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Gain Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
215 documents on file, from Dec 14, 2020 to Oct 1, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.